In Silico Screening for Potent Inhibitors against the NS3/4A Protease of Hepatitis C Virus

E-ISSN： 1873-4286|20|21|3465-3477

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.21, 2014-05, pp. : 3465-3477

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in the Development of Macrocyclic Inhibitors of Hepatitis C Virus NS3-4A Protease

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1403-1422

Bentham Science Publishers

Access to resources Recommend Favorite

The Second-generation of Highly Potent Hepatitis C Virus (HCV) NS3/4A Protease Inhibitors: Evolutionary Design Based on Tailor-made Amino Acids, Synthesis and Major Features of Bio-activity

Current Pharmaceutical Design, Vol. 23, Iss. 30, 2017-11 ,pp. : 4493-4554

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Hepatitis C Virus NS3.4A Protease: P2 Proline Variants

Letters in Drug Design & Discovery, Vol. 2, Iss. 7, 2005-01 ,pp. : 497-502

Bentham Science Publishers

Access to resources Recommend Favorite

Macrocyclic Hepatitis C Virus NS3/4A Protease Inhibitors: An Overview of Medicinal Chemistry

Current Medicinal Chemistry, Vol. 23, Iss. 29, 2016-10 ,pp. : 3404-3447

Bentham Science Publishers

Access to resources Recommend Favorite

Novel tripeptide inhibitors of hepatitis C virus NS3 serine protease

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 267-272

Informa Healthcare

Access to resources Recommend Favorite